Exempting Drugs from Affordability Reviews Puts Patients at Risk AARP

Exempting Drugs from Affordability Reviews Puts Patients at Risk

Stop Big Pharma and tell your lawmaker to vote NO on Exempting Drugs from Prescription Drug Affordability Board Reviews 
 

Older Coloradans and many working families already cannot keep up with the skyrocketing costs of prescription medications. In 2021, advocates like you helped create Colorado’s Prescription Drug Affordability Board (PDAB). Pharmaceutical companies are so nervous about having fair prices that they are fighting “tooth and nail” to pass the Exempt Drugs from Prescription Drug Affordability Board Reviews bill, which could prevent the PDAB from reviewing hundreds of medications.
 

 

RECIPIENTS:

  • Your State Senator
Form Label Field
Your Message
Dear Decision Maker,

I am an AARP member and your constituent. Coloradans 50-plus and working families cannot keep up with the skyrocketing costs of prescription medications. Our lawmakers must fight so we can afford the critical medicines we need. Big Pharma is trying to protect its profits through Senate Bill 26-140 and weaken the Prescription Drug Affordability Board (PDAB). The board is Colorado’s best tool to lower drug costs. I strongly urge you to vote NO on SB26-140.

The Prescription Drug Affordability Board was created by Colorado patients, consumer advocates, and lawmakers to rein in the costs of prescription medications. This board gives me hope that our state will be able to lower medication costs. Because SB 140 is written so broadly, high-priced drugs with the government designation of “orphan status,” which are also used to treat common health conditions, could still be exempt from PDAB’s affordability review. Colorado’s PDAB must be able to continue to thoroughly review and consider whether to set upper payment limits on all types of high-cost drugs.

Put Colorado patients first, not Big Pharma. Vote NO on SB26-140!

Thank you.

[First Name] [Last Name]
[Your Address]